-
Several large observational studies have suggested that vitamin E supplementation lowers the risk of coronary heart disease. However, the results of large randomized controlled trials failed to show a clear benefit of a-tocopherol supplementation on cardiovascular outcomes.
-
Subgroups of U.S. adults who are minorities, poor, or undereducated with chronic cardiovascular risk factors such as hypertension, diabetes, and hypercholesterolemia have large disparities in treatment for these conditions compared with white, high school-educated adults when they are uninsured or underinsured.
-
According to results of a gallup organization survey released during the American College of Obstetricians and Gynecologists (ACOG) 57th Annual Clinical meeting in Chicago, women are delaying important preventive care—in the form of pregnancy and annual check-ups—as a result of the economy.
-
In-depth laboratory analysis suggests that human semen (SE) contains a peptide that enhances HIV infectivity, but the green tea polyphenol epigallocatechin-3-gallate (EGCG) inhibits the increased infectivity associated with the peptide. This raises the possibility that topical intravaginal EGCG could be a useful adjunct in controlling the spread of HIV infection.
-
A randomized, double-blind study found that alpha-linolenic acid (an omega-3 fatty acid) supplementation provided few additional benefits for older adults participating in a 12-week resistance-training program.
-
This brief pilot intervention trial grew out of data suggesting that symptoms of fibromyalgia are often worse during cold weather, and that the skin temperature associated directly with specific trigger points may be lower than in healthy subjects.
-
Heart failure (HF), the end result of many cardiovascular disorders and a common disabling clinical syndrome, affects almost 6 million people in the United States.
-
A brief intervention of an extract of ginger administered four times daily was effective in ameliorating nausea and vomiting of pregnancy in this small single-blind trial.
-
Upon evaluating data from the STAR*D project, researchers concluded that phase III clinical trials often do not recruit representative populations of depressed outpatients, making the recommendations drawn from the studies' conclusions of limited applicability to general clinical practice.
-
This small pilot study represents the first controlled assessment of intravenous micronutrient therapy for fibromyalgia. No statistically significant benefit over placebo was identified, though clinical benefit was apparent, and feasibility was established. Regardless of one's bias regarding this type of care, further study is needed.
